Inventor · disambiguated record
Sebastien Caille
Also filed as: CAILLE SEBASTIEN
13 granted patents·9 pending applications·88 citations·filing 2014–2025
92Inventor score
Files withAMGEN INC22
Top patents by PatentIndex Score
22 records- 0195US11753394B2Synthesis of omecamtiv mecarbilAMGEN INC·Filed 2021·Granted Sep 12, 2023·9 cites·7 claims
- 0295US11040956B2Synthesis of omecamtiv mecarbilAMGEN INC·Filed 2018·Granted Jun 22, 2021·23 cites·14 claims
- 0394US9623018B2Processes of making and crystalline forms of a MDM2 inhibitorAMGEN INC·Filed 2016·Granted Apr 18, 2017·6 cites·28 claims
- 0493US11465969B2Salts and crystal forms of omecamtiv mecarbilAMGEN INC·Filed 2019·Granted Oct 11, 2022·16 cites·32 claims
- 0592US11926592B2Salts and crystal forms of omecamtiv mecarbilAMGEN INC·Filed 2022·Granted Mar 12, 2024·8 cites·21 claims
- 0692US11702380B2Synthesis of omecamtiv mecarbilAMGEN INC·Filed 2022·Granted Jul 18, 2023·13 cites·59 claims
- 0790US12269811B2Synthesis of omecamtiv mecarbilAMGEN INC·Filed 2023·Granted Apr 8, 2025·1 cites·13 claims
- 0890US9376386B2Processes of making and crystalline forms of a MDM2 inhibitorAMGEN INC·Filed 2014·Granted Jun 28, 2016·7 cites·48 claims
- 0985US9801867B2Processes of making and crystalline forms of a MDM2 inhibitorAMGEN INC·Filed 2016·Granted Oct 31, 2017·2 cites·30 claims
- 1084US2023301974A1Processes of making and crystalline forms of a mdm2 inhibitorAMGEN INC·Filed 2023·Application pending·0 cites
- 1181US12473281B2Synthesis of KRAS G12C inhibitor compoundAMGEN INC·Filed 2020·Granted Nov 18, 2025·1 cites·30 claims
- 1278US9757367B2Calcium propane-2-sulfinate dihydrateAMGEN INC·Filed 2016·Granted Sep 12, 2017·1 cites·2 claims
- 1377US9855259B2Processes of making and crystalline forms of a MDM2 inhibitorAMGEN INC·Filed 2016·Granted Jan 2, 2018·1 cites·14 claims
- 1477US2025206736A1Synthesis of kras g12c inhibitor compoundAMGEN INC·Filed 2024·Application pending·0 cites
- 1575US2022280496A1Processes of making and crystalline forms of a mdm2 inhibitorAMGEN INC·Filed 2021·Application pending·0 cites
- 1674US2020281912A1Processes of making and crystalline forms of a mdm2 inhibitorAMGEN INC·Filed 2019·Application pending·0 cites
- 1771US2024199550A1Salts and crystal forms of omecamtiv mecarbilAMGEN INC·Filed 2024·Application pending·0 cites
- 1870US2018092898A1Processes of making and crystalline forms of a mdm2 inhibitorAMGEN INC·Filed 2017·Application pending·0 cites
- 1970US2025163023A1Synthesis of omecamtiv mecarbilAMGEN INC·Filed 2025·Application pending·0 cites
- 2068US2025295647A1Processes of making and crystalline forms of a mdm2 inhibitorAMGEN INC·Filed 2024·Application pending·0 cites
- 2158US2025129050A1Synthesis of a kif18a inhibitorAMGEN INC·Filed 2023·Application pending·0 cites
- 2257US11753386B2Processes for preparing a MDM2 inhibitorAMGEN INC·Filed 2019·Granted Sep 12, 2023·0 cites·6 claims
Join the waitlist — get patent alerts
Get an alert when Sebastien Caille files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →